Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Coronavirus: 5 states to receive first batch of Hetero's COVIFOR
India

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR
Written by Siddhant Pandey
Jun 25, 2020, 04:47 pm 3 min read
Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

Five states across India will be the first to receive Hetero Healthcare's COVID-19 drug, COVIFOR, the first generic brand of the experimental drug remdesivir. The Hyderabad-based drugmaker has sent the first consignment of 20,000 vials to five states, NDTV reported. Among the states to receive the first consignment are Maharashtra and Delhi, two of the worst-affected regions in India. Here are more details.

Details
These states will receive first consignment

According to NDTV, Hetero has sent the first batch of COVIFOR to Maharashtra, Delhi, Gujarat, Tamil Nadu, along with Telangana's capital Hyderabad. These are notably regions where the COVID-19 outbreak has had one of the worst impacts. Reportedly, the next batch of the drug will be sent to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneswar, Ranchi, Vijayawada, Kochi, Trivandrum, and Goa.

Drug
Drug regulator approved Hetero's COVIFOR

COVIFOR is the generic version of antiviral drug remdesivir. The Drug Controller General of India (DCGI) had given approval to both Hetero and Cipla to manufacture and sell COVIFOR for restricted emergency use in severe COVID-19 cases. The drug has received emergency use approval for severely ill patients in South Korea and the United States, and full approval in Japan.

Information
COVIFOR being manufactured at Hetero's Hyderabad facility

Currently, the drug is being manufactured at Hetero's formulation facility in Hyderabad, while the active pharmaceutical ingredient (API) is being made at the firm's Visakhapatnam facility. The company is aiming to produce one lakh COVIFOR vials in three-four weeks.

Hetero
COVIFOR 100 mg vials to be sold at Rs. 5,400

Hetero would sell COVIFOR in the form of 100 mg vials that will be administered intravenously. The recommended dose for adults and pediatric patients is 200 mg on day one, followed by daily maintenance doses of 100 mg for the next five days. Each vial will cost Rs. 5,400. Cipla has said that its version of remdesivir would be priced below Rs 5,000.

Information
Drug will only be sold by hospitals, government

Hetero Group of Companies MD Vamsi Krishna Bandi told NDTV, "The drug will not be given to those with liver disease, kidney failure, pregnant or lactating women, and children below 12 years." Bandi has said COVIFOR will only be sold through hospitals and the government.

Outbreak
India reports 4.73 lakh COVID-19 cases, 14,900 deaths

According to the Union Health Ministry, as of 8 am on Thursday, India has reported a total of 4,73,105 cases. The total includes 14,894 deaths and 1,86,514 active cases along with 2,71,696 patients who have been cured or discharged and one patient who migrated out of India. India reported nearly 17,000 cases in the past 24 hours, marking the biggest single-day spike.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
South Korea
Telangana
Tamil Nadu
Gujarat
Maharashtra
Related
Latest
China's Tianwen-1 orbiter has photographed the entire surface of Mars
China's Tianwen-1 orbiter has photographed the entire surface of Mars Technology
Shuri's 'Black Panther 2' look criticized; 'Recast T'Challa' trends online
Shuri's 'Black Panther 2' look criticized; 'Recast T'Challa' trends online Entertainment
Nabbed terrorist linked to J&K BJP Minority Morcha IT cell
Nabbed terrorist linked to J&K BJP Minority Morcha IT cell India
Hrithik refused to shoot in Lucknow? 'Vikram Vedha' makers clarify
Hrithik refused to shoot in Lucknow? 'Vikram Vedha' makers clarify Entertainment
Singapore: Beer made with recycled toilet water wins over netizens
Singapore: Beer made with recycled toilet water wins over netizens Lifestyle
South Korea
K-beauty vs J-beauty: Know the difference
K-beauty vs J-beauty: Know the difference Lifestyle
J-Hope's solo 'Jack in the Box': Release date, first-look images
J-Hope's solo 'Jack in the Box': Release date, first-look images Entertainment
'Proof' dominates Billboard charts: All achievements of BTS's latest album
'Proof' dominates Billboard charts: All achievements of BTS's latest album Entertainment
Fans go gaga over BTS's Jungkook, Charlie Puth's collaboration
Fans go gaga over BTS's Jungkook, Charlie Puth's collaboration Entertainment
North Korea reports 'mysterious' gastrointestinal disease outbreak amid COVID-19 wave
North Korea reports 'mysterious' gastrointestinal disease outbreak amid COVID-19 wave World
More News
Telangana
No roll-back of Agnipath scheme, all concessions pre-planned: Defence Ministry
No roll-back of Agnipath scheme, all concessions pre-planned: Defence Ministry India
Agnipath: Protests spread to more states, over 360 trains canceled
Agnipath: Protests spread to more states, over 360 trains canceled India
Hyderabad: Woman sexually assaulted by friend after birthday party
Hyderabad: Woman sexually assaulted by friend after birthday party India
Agnipath scheme: Protesters burn trains; vandalism, violence leave 1 dead
Agnipath scheme: Protesters burn trains; vandalism, violence leave 1 dead India
Prophet remarks: Protests outside UP, Delhi mosques after Friday prayers
Prophet remarks: Protests outside UP, Delhi mosques after Friday prayers India
More News
Tamil Nadu
5 healthy and tasty dosa varieties
5 healthy and tasty dosa varieties Lifestyle
Newlyweds Nayanthara, Vignesh Shivan caught in controversy over Tirupati visit
Newlyweds Nayanthara, Vignesh Shivan caught in controversy over Tirupati visit Entertainment
Rajya Sabha polls: BJP clinches Karnataka, Haryana; Congress bags Rajasthan
Rajya Sabha polls: BJP clinches Karnataka, Haryana; Congress bags Rajasthan Politics
5 best places in India for coffee lovers
5 best places in India for coffee lovers Lifestyle
Rajya Sabha polls: Tight contest underway in 4 states
Rajya Sabha polls: Tight contest underway in 4 states Politics
More News
Gujarat
Vadodara girl adopts zoo leopard after losing her pet dog
Vadodara girl adopts zoo leopard after losing her pet dog Lifestyle
Gujarat: SIT to probe conspiracy allegations against Teesta, two others
Gujarat: SIT to probe conspiracy allegations against Teesta, two others India
Gujarat riots: Meet Teesta Setalvad, the co-petitioner against PM Modi
Gujarat riots: Meet Teesta Setalvad, the co-petitioner against PM Modi India
Meet Abbas bhai, who Modi mentioned as friend in blog
Meet Abbas bhai, who Modi mentioned as friend in blog India
#NewsBytesExplainer: Why Russia-Ukraine war is hitting Gujarat's diamond industry hard?
#NewsBytesExplainer: Why Russia-Ukraine war is hitting Gujarat's diamond industry hard? Business
More News
Maharashtra
Maharashtra: Chief Minister Eknath Shinde wins trust vote by 164-99
Maharashtra: Chief Minister Eknath Shinde wins trust vote by 164-99 Politics
Maharashtra: Eknath Shinde-led government to face floor test today
Maharashtra: Eknath Shinde-led government to face floor test today Politics
Protest against Metro Car Shed in Aarey gains steam again
Protest against Metro Car Shed in Aarey gains steam again India
Mumbai: Siblings arrested for impersonating as beggars, conducting thefts
Mumbai: Siblings arrested for impersonating as beggars, conducting thefts Mumbai
BJP's Rahul Narwekar elected Maharashtra Assembly Speaker, defeats Sena's Salvi
BJP's Rahul Narwekar elected Maharashtra Assembly Speaker, defeats Sena's Salvi Politics
More News
Related
How does Merck's new COVID-19 drug work?
How does Merck's new COVID-19 drug work? Technology
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022